138 related articles for article (PubMed ID: 29239931)
21. Endometriosis in the setting of Muckle-Wells syndrome treated with an IL-1β antagonist.
Sasaki-Saito N; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Eur J Dermatol; 2017 Aug; 27(4):442-443. PubMed ID: 28508753
[No Abstract] [Full Text] [Related]
22. CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME-ASSOCIATED UVEITIS AND PAPILLITIS.
Ma L; Lee S; Montieth A; Stephenson A; Foster CS; Anesi SD
Retin Cases Brief Rep; 2021 Mar; 15(2):149-154. PubMed ID: 30134363
[TBL] [Abstract][Full Text] [Related]
23. Muckle-Wells syndrome without mutation in exon 3 of the NLRP3 gene, identified by evidence of excessive monocyte production of functional interleukin 1β and rapid response to anakinra.
Sabroe RA; Stokes CA; Parker LC; Higgins K; Prince LR; Sabroe I
Clin Exp Dermatol; 2013 Dec; 38(8):874-7. PubMed ID: 23889084
[TBL] [Abstract][Full Text] [Related]
24. Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome.
Enríquez R; Sirvent AE; Padilla S; Noguera-Pons R; Andrada E; Ardoy F; Millán I; Amorós F
Ren Fail; 2013; 35(5):738-41. PubMed ID: 23650909
[TBL] [Abstract][Full Text] [Related]
25. Anakinra desensitisation in patients with cryopyrin-associated periodic syndromes.
Ali SB; Le TA; Kette F; Hissaria P
Clin Exp Rheumatol; 2021; 39(1):13-16. PubMed ID: 33427612
[TBL] [Abstract][Full Text] [Related]
26. Renal and thyroid amyloidosis secondary tocryopyrin-associated periodic syndrome(Muckle-Wells syndrome) (NLRP3 mutation).
Bolaños L; Mosquera-Reboredo JM; Cao M; Ferreiro T; Veleiro B; Valdés F; Vázquez-Martul E
Nefrologia; 2013; 33(2):266-71. PubMed ID: 23511763
[No Abstract] [Full Text] [Related]
27. Neonatal urticaria: Could it be CAPS?
Cutts L; Parslew R; Eustace K
Pediatr Dermatol; 2018 Nov; 35(6):e420-e421. PubMed ID: 30187963
[TBL] [Abstract][Full Text] [Related]
28. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra.
Mirault T; Launay D; Cuisset L; Hachulla E; Lambert M; Queyrel V; Quemeneur T; Morell-Dubois S; Hatron PY
Arthritis Rheum; 2006 May; 54(5):1697-700. PubMed ID: 16646042
[TBL] [Abstract][Full Text] [Related]
29. Anakinra use during pregnancy in patients with cryopyrin-associated periodic syndromes (CAPS).
Chang Z; Spong CY; Jesus AA; Davis MA; Plass N; Stone DL; Chapelle D; Hoffmann P; Kastner DL; Barron K; Goldbach-Mansky RT; Stratton P
Arthritis Rheumatol; 2014 Nov; 66(11):3227-32. PubMed ID: 25223501
[TBL] [Abstract][Full Text] [Related]
30. Auto-Inflammatory Syndromes Revealing Hematological Disorders and Anakinra Efficacy in 2 Cases.
Brevet P; Curie A; Princivil C; Zarnitsky C; Alcaix D
J Clin Rheumatol; 2021 Dec; 27(8S):S403-S404. PubMed ID: 32496361
[No Abstract] [Full Text] [Related]
31. Muckle-Wells syndrome: individualized, reflare-guided dosing of the orphan drug canakinumab.
Mueller SM; Itin P; Haeusermann P
Skinmed; 2013; 11(2):80-3. PubMed ID: 23745225
[No Abstract] [Full Text] [Related]
32. Severe cryopyrin-associated periodic syndrome first characterized by early childhood-onset sensorineural hearing loss - Case report and literature review.
Hui A; Johnson LB; Greemberg R; Penney L; Ramsey SE
Int J Pediatr Otorhinolaryngol; 2019 May; 120():68-72. PubMed ID: 30772614
[TBL] [Abstract][Full Text] [Related]
33. Cryopyrin-associated periodic syndrome in early childhood can be successfully treated with interleukin-1 blockades.
Eskola V; Pohjankoski H; Kröger L; Aalto K; Latva K; Korppi M
Acta Paediatr; 2018 Apr; 107(4):577-580. PubMed ID: 29331074
[TBL] [Abstract][Full Text] [Related]
34. Post-inflammatory retinal dystrophy in CINCA syndrome.
Rigante D; Stabile A; Minnella A; Avallone L; Ziccardi L; Bersani G; Stifano G; Compagnone A; Falsini B
Rheumatol Int; 2010 Jan; 30(3):389-93. PubMed ID: 19424698
[TBL] [Abstract][Full Text] [Related]
35. Muckle-Wells Syndrome: A Case Report with an NLRP3 T348M Mutation.
Naz Villalba E; Gomez de la Fuente E; Caro Gutierrez D; Pinedo Moraleda F; Yanguela Rodilla J; Mazagatos Angulo D; López Estebaranz JL
Pediatr Dermatol; 2016 Sep; 33(5):e311-4. PubMed ID: 27435956
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Efficacy of Anakinra in Cryopyrin-Associated Periodic Syndrome: Focus on Destructive Arthropathy.
Kim YH; Kim BJ; Han J; Choi BY; Lee S
J Clin Immunol; 2021 Nov; 41(8):1936-1939. PubMed ID: 34346012
[No Abstract] [Full Text] [Related]
37. [Papillary edema in Muckle-Wells syndrome].
Wirths G; Grenzebach U; Eter N
Ophthalmologe; 2015 Sep; 112(9):778-82. PubMed ID: 25614348
[TBL] [Abstract][Full Text] [Related]
38. Cryopyrin-associated periodic syndrome.
Posch C; Kaulfersch W; Rappersberger K
Pediatr Dermatol; 2014; 31(2):228-31. PubMed ID: 22891689
[TBL] [Abstract][Full Text] [Related]
39. Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomes.
Sibley CH; Plass N; Snow J; Wiggs EA; Brewer CC; King KA; Zalewski C; Kim HJ; Bishop R; Hill S; Paul SM; Kicker P; Phillips Z; Dolan JG; Widemann B; Jayaprakash N; Pucino F; Stone DL; Chapelle D; Snyder C; Butman JA; Wesley R; Goldbach-Mansky R
Arthritis Rheum; 2012 Jul; 64(7):2375-86. PubMed ID: 22294344
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of interleukin-1 inhibitors in familial Mediterranean fever patients complicated with amyloidosis.
Varan Ö; Kucuk H; Babaoglu H; Guven SC; Ozturk MA; Haznedaroglu S; Goker B; Tufan A
Mod Rheumatol; 2019 Mar; 29(2):363-366. PubMed ID: 29578360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
